| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.007 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.008 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.009 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.16 | 0.009 |